Echinocandins, New Class of Antifungals, Improving Care of Immunocompromised Cancer Patients
Peggy Eastman
openalex +1 more source
FKS2 Mutations Associated with Decreased Echinocandin Susceptibility of Candida glabrata following Anidulafungin Therapy [PDF]
Sofia Costa‐de‐Oliveira +7 more
openalex +1 more source
Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum [PDF]
Berényi, Réka +6 more
core +1 more source
Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance? [PDF]
Carolus H +13 more
europepmc +1 more source
In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species [PDF]
David R. Andes +5 more
openalex +1 more source
A Candidozyma (Candida) auris-Optimized Episomal Plasmid-Induced Cas9-Editing System Reveals the Direct Impact of the S639F-Encoding FKS1 Mutation. [PDF]
Doorley LA +3 more
europepmc +1 more source
Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance [PDF]
Ronen Ben‐Ami +6 more
openalex +1 more source
A screen to identify antifungal antagonists reveals a variety of pharmacotherapies that induce echinocandin tolerance in <i>Candida albicans</i>. [PDF]
Reitler P +7 more
europepmc +1 more source

